Pages that link to "Q35994122"
Jump to navigation
Jump to search
The following pages link to Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma (Q35994122):
Displaying 50 items.
- Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities (Q27687777) (← links)
- Effect of hormone replacement therapy on markers of bone metabolism in RA (Q33565927) (← links)
- Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis (Q33565980) (← links)
- Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis (Q33578907) (← links)
- Prognostic factors in multiple myeloma (Q33811615) (← links)
- Multiple myeloma: changes in serum C-terminal telopeptide of collagen type I and bone-specific alkaline phosphatase can be used in daily practice to detect imminent osteolysis (Q33854017) (← links)
- Markers of bone turnover in bone metastases (Q33970497) (← links)
- Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients (Q34067081) (← links)
- Biochemical markers to survey bone turnover (Q34207030) (← links)
- Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy. (Q34409098) (← links)
- Increased degradation of type I collagen in patients with inflammatory bowel disease (Q34409296) (← links)
- Bone metabolic markers as gauges of metastasis to bone: a review (Q34748711) (← links)
- Bisphosphonate therapy in multiple myeloma: past, present, future (Q35013342) (← links)
- Matrix molecules and growth factors as indicators of periodontal disease activity (Q35092094) (← links)
- Elevated carboxy terminal cross linked telopeptide of type I collagen in alcoholic cirrhosis: relation to liver and kidney function and bone metabolism (Q35354293) (← links)
- Matrix Metalloproteinase Mediated Type I Collagen Degradation - An Independent Risk Factor for Mortality in Women. (Q38637519) (← links)
- Type I and type III collagen metabolites in adult osteosarcoma patients (Q36134368) (← links)
- Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma (Q36134836) (← links)
- Usefulness of bone metabolic markers in the diagnosis and follow-up of bone metastasis from lung cancer (Q36431117) (← links)
- Biochemical markers of bone metabolism in multiple myeloma (Q36471234) (← links)
- Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group (Q36571329) (← links)
- Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma. (Q36622607) (← links)
- Application of biochemical markers in development of drugs for treatment of osteoarthritis (Q37677789) (← links)
- Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar. (Q38218544) (← links)
- Evaluation of bone loss and the serum markers of bone metabolism in patients with hyperparathyroidism (Q39371488) (← links)
- Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the finnish prostate cancer group (Q39497802) (← links)
- Clodronate and other bisphosphonates as supportive therapy in osteolysis due to malignancy (Q40405369) (← links)
- Biochemical markers of bone turnover:A review (Q40483632) (← links)
- Prognosis in myeloma (Q40691843) (← links)
- Crevicular fluid osteocalcin and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as markers of rapid bone turnover in periodontitis. A pilot study in beagle dogs (Q40964514) (← links)
- Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment. (Q41346437) (← links)
- Biochemical Markers of Bone Metabolism: An Overview (Q41696180) (← links)
- Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer (Q42002897) (← links)
- Growth hormone treatment in adults with GH deficiency: effects on new biochemical markers of bone and collagen turnover (Q42499439) (← links)
- Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism (Q44101930) (← links)
- Effect of locally delivered minocycline microspheres on markers of bone resorption (Q44125466) (← links)
- Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patients (Q44170314) (← links)
- Changes in serological biomarkers of liver function and connective tissue turnover in chronic hepatitis B during lamivudine therapy (Q46820502) (← links)
- Synthesis and maturation of type I and type III collagens in endometrial adenocarcinoma (Q47274787) (← links)
- Serum levels of carboxyterminal propeptide of type I procollagen and pyridinoline crosslinked telopeptide of type I collagen in normal children and children with growth hormone (GH) deficiency during GH therapy (Q51040336) (← links)
- Comparison of five biochemical markers of bone resorption in multiple myeloma: elevated pre-treatment levels of S-ICTP and U-Ntx are predictive for early progression of the bone disease during standard chemotherapy (Q51538830) (← links)
- Biochemical markers of bone turnover in breast cancer patients with bone metastases: a preliminary report (Q51564833) (← links)
- Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study (Q51584337) (← links)
- Intranasal calcitonin suppresses increased bone resorption during short-term immobilization: a double-blind study of the effects of intranasal calcitonin on biochemical parameters of bone turnover (Q51597869) (← links)
- Multiple molecular forms of pyridinolines cross-links excreted in human urine evaluated by chromatographic and immunoassay methods (Q52332392) (← links)
- Changes in serum carboxyterminal telopeptide of type I collagen in an experimental model of canine osteomyelitis (Q54047037) (← links)
- Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patients (Q58050924) (← links)
- Myeloma bone disease (Q60482582) (← links)
- Urinary excretion of pyridinolines crosslinks measured by immunoassay and HPLC techniques in normal subjects and in elderly patients with vitamin D deficiency (Q72405079) (← links)
- Pyridinium cross-links in multiple myeloma: correlation with clinical parameters and use for monitoring of intravenous clodronate therapy--a pilot study of the German Myeloma Treatment Group (GMTG) (Q73027614) (← links)